Investors' Confidence in DexCom (DXCM) Rises as Growth Outlook Reassured
Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 6,873,273 | $462,914,937 | +171% | 0.21% |
| 2. | Castle Hook Partners Josh Donfeld And David Rogers | 3,870,342 | $260,667,534 | +383% | 1.2% |
| 3. | AQR Capital Management Cliff Asness | 3,237,720 | $218,060,428 | +49% | 0.08% |
| 4. | Renaissance Technologies Jim Simons | 1,630,796 | $109,834,111 | +4% | 0.15% |
| 5. | 90,144,000 | $84,205,112 | +141% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.43 | 2,500 | $138,563.00 | 331,697 | 2025-11-10 | Filing | |
| $54.98 | 15,700 | $863,138.90 | 329,197 | 2025-11-10 | Filing | |
| $50.01 | 25,000 | $1,250,250.00 | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | $496,100.00 | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | $1,085,000.00 | 121,975 | 2013-03-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.15 | 2,565 | $220,974.75 | 123,478 | 2026-09-28 | Filing | |
| $84.04 | 6,539 | $549,537.56 | 29,293 | 2026-09-15 | Filing | |
| $84.02 | 1,550 | $130,231.00 | 35,832 | 2026-09-14 | Filing | |
| $84.04 | 1,700 | $142,868.00 | 99,885 | 2026-09-15 | Filing | |
| $83.27 | 3,638 | $302,936.26 | 146,828 | 2026-09-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,589 | $309,695 | 0.03% | |
| 2. | 1,366 | $117,872 | 0.04% | |
| 3. | 80 | $6,903 | 0% | |
| 4. | 71 | $6,127 | 0% | |
| 5. | 17 | $1,467 | 0% |
News See All
10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds
In this article, we will discuss: 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.
12 High Quality Stocks to Buy for the Long Term
In this article, we will look at the 12 High Quality Stocks to Buy for the Long Term.
Analysts Upgrade DexCom (DXCM) to “Outperform,” Driving Share Recovery
Alpha Wealth Funds, LLC, an investment management company, released its Q1 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here.
10 Stocks Dominating With Powerful Gains
Ten stocks ended the last trading day of the week boasting significant gains, as investors continued to digest a flurry of strong corporate earnings in the first quarter of the year.
12 Best Growth Stocks to Invest In for the Next 2 Years
In this article, we will discuss the 12 Best Growth Stocks to Invest In for the Next 2 Years.
DexCom, Inc. (NASDAQ:DXCM) Q1 2026 Earnings Call Transcript
DexCom, Inc. (NASDAQ:DXCM) Q1 2026 Earnings Call Transcript April 30, 2026DexCom, Inc. beats earnings expectations. Reported EPS is $0.52, expectations were $0.47.
BTIG Remains Bullish on DexCom, Inc. (DXCM)
DexCom, Inc. (NASDAQ:DXCM) is one of the best medical device stocks to invest in right now. BTIG cut the price target on DexCom, Inc.
10 Best Medical Device Stocks to Invest In Right Now
In this article, we will look at the 10 Best Medical Device Stocks to Invest In Right Now.
Is DexCom, Inc. (DXCM) A Good Stock To Buy Now?
Is DXCM a good stock to buy? We came across a bullish thesis on DexCom, Inc. on Part-Time Compounder’s Substack by Francesco Ferrari. In this article, we will summarize the bulls’ thesis on DXCM.
Hedge Fund Resource Center